- Home
- VYGR vs CURI Comparison
VYGR vs CURI Comparison
Compare VYGR & CURI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYGR
- CURI
- Stock Information
- Founded
- VYGR 2013
- CURI N/A
- Country
- VYGR United States
- CURI United States
- Employees
- VYGR N/A
- CURI N/A
- Industry
- VYGR Biotechnology: Pharmaceutical Preparations
- CURI Movies/Entertainment
- Sector
- VYGR Health Care
- CURI Consumer Discretionary
- Exchange
- VYGR Nasdaq
- CURI Nasdaq
- Market Cap
- VYGR 231.9M
- CURI 264.7M
- IPO Year
- VYGR 2015
- CURI N/A
- Fundamental
- Price
- VYGR $4.69
- CURI $5.14
- Analyst Decision
- VYGR Strong Buy
- CURI Strong Buy
- Analyst Count
- VYGR 8
- CURI 3
- Target Price
- VYGR $16.71
- CURI $6.00
- AVG Volume (30 Days)
- VYGR 789.3K
- CURI 533.6K
- Earning Date
- VYGR 11-11-2025
- CURI 11-05-2025
- Dividend Yield
- VYGR N/A
- CURI 6.30%
- EPS Growth
- VYGR N/A
- CURI N/A
- EPS
- VYGR N/A
- CURI N/A
- Revenue
- VYGR $42,580,000.00
- CURI $60,840,000.00
- Revenue This Year
- VYGR N/A
- CURI $34.86
- Revenue Next Year
- VYGR $107.10
- CURI $9.69
- P/E Ratio
- VYGR N/A
- CURI N/A
- Revenue Growth
- VYGR N/A
- CURI 11.02
- 52 Week Low
- VYGR $2.65
- CURI $1.47
- 52 Week High
- VYGR $8.28
- CURI $7.15
- Technical
- Relative Strength Index (RSI)
- VYGR 62.56
- CURI 57.47
- Support Level
- VYGR $4.32
- CURI $4.95
- Resistance Level
- VYGR $5.06
- CURI $5.34
- Average True Range (ATR)
- VYGR 0.29
- CURI 0.27
- MACD
- VYGR 0.02
- CURI -0.01
- Stochastic Oscillator
- VYGR 64.59
- CURI 57.23
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.
About CURI CuriosityStream Inc.
CuriosityStream Inc is a media and entertainment company. It offers premium video programming across the principal categories of factual entertainment, including science, history, society, nature, lifestyle, and technology. Its mission is to provide premium real entertainment that informs, enchants, and inspires. Its product and services are Direct to Consumer Business, Partner Direct Business, Bundled Distribution, Content Licensing, Enterprise Subscriptions and Others. The majority of the revenue comes from the Direct to direct-to-consumer business.